New Publication from Xiang Lab in Cell Mol Immunol

"TLR9 agonist enhances radiofrequency ablation-induced CTL responses, leading to the potent inhibition of primary tumor growth and lung metastasis"



Authors: Xu A, Zhang L, Yuan J, Babikr F, Freywald A, Chibbar R, Moser M, Zhang W, Zhang B, Fu Z, Xiang J.

Cell Mol Immunol. 2018 Nov 22. doi: 10.1038/s41423-018-0184-y. [Epub ahead of print]

PMID: 30467420

 The paper can be accessed here: https://www.ncbi.nlm.nih.gov/pubmed/30467420
Share this story